Your session is about to expire
← Back to Search
Social Stress Test for Social Anxiety (SSBI Trial)
N/A
Waitlist Available
Led By John D.E. Gabrieli, PhD
Research Sponsored by Massachusetts Institute of Technology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1
Awards & highlights
No Placebo-Only Group
Summary
This trial looks at how stress affects the brain, and whether it affects how we think and feel.
Who is the study for?
This trial is for healthy English-speaking adults aged 18-55 who can consent to participate. They must be right-handed, not pregnant, drug-free, and without significant mental health issues or severe medical conditions. Participants should not have used certain medications recently and must pass a social anxiety scale test.
What is being tested?
The study is testing how experiencing social stress affects brain activity in healthy individuals. It uses the Trier Social Stress Test (TSST) followed by neuroimaging to observe changes in brain activation patterns.
What are the potential side effects?
Since this trial involves a stress test and MRI scans, side effects may include temporary stress-related responses such as increased heart rate or anxiety during the TSST, and discomfort or claustrophobia during MRI scanning.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 1
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Differences in fMRI BOLD Response
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Film + TSSTExperimental Treatment1 Intervention
Nature Film + Trier Social Stress Test (TSST)
Group II: Film Only (No-TSST)Active Control1 Intervention
Nature Film Only
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Trier Social Stress Test (TSST)
2020
N/A
~210
Find a Location
Who is running the clinical trial?
Massachusetts Institute of TechnologyLead Sponsor
101 Previous Clinical Trials
12,821,975 Total Patients Enrolled
Massachusetts General HospitalOTHER
3,026 Previous Clinical Trials
13,413,739 Total Patients Enrolled
John D.E. Gabrieli, PhDPrincipal InvestigatorMassachusetts Institute of Technology
1 Previous Clinical Trials
50 Total Patients Enrolled
John Gabrieli, PhDPrincipal InvestigatorMassachusetts Institute of Technology
4 Previous Clinical Trials
382 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 18 and 55 years old.I have been diagnosed with diabetes.I have not used any cannabis products in the last 30 days.I have used beta-blockers or benzodiazepines in the last 2 weeks.I do not have major neurological or cognitive issues like seizures or dementia.
Research Study Groups:
This trial has the following groups:- Group 1: Film + TSST
- Group 2: Film Only (No-TSST)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.